Trademarks / Class 5 / XCELLDERMA

XCELLDERMA

SN 99532907 never registeredPrincipal RegisterUSPTO TSDR ↗
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
Mark · Trademark
XCELLDERMA - official mark drawing from the USPTO record

What this record means

The record shows that XCELLDERMA is an abandoned application – the USPTO marked it “dead” after the applicant, Regenerex Pharma, Inc., failed to respond to an Office action, with the abandonment notice dated November 3 2026. The filing, made on December 5 2025, listed goods in International Class 5 covering medical and pharmaceutical preparations for wound care, including antiseptics, dressings and products aimed at healing or reducing odor in wounds, ulcers, burns and graft sites. Because the claim is limited to those pharmaceutical wound‑care items, a similar name used for unrelated products such as cosmetics, software or food would be farther from the scope shown here, though the record does not give the owner control over every possible use of the word. The prosecution history shows only the filing, an examiner assignment, a non‑final action in April 2026, an extension of time, and finally the abandonment; no oppositions, cancellations or court actions appear. I'd treat this as a meaningful concern if you plan a name in the same wound‑care pharmaceutical space.

Informational only - not legal advice.

Mark Trademark

XCELLDERMA
Standard-character drawing · USPTO TSDR, retrieved Nov 17, 2026
Drawing type4 - STANDARD CHARACTER MARK
Filing basisIntent-to-Use (§1(b)).
StatusAbandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.

Key dates

Application filedDec 05, 2025
Status dateNov 03, 2026

Goods & services

Cl. 005PharmaceuticalsACTIVE

medical preparations, namely, wound care preparations; antiseptic preparations for medical, surgical and veterinary use; pharmaceutical preparations for wound care for application to necrotic wounds, ulcers, surgical wounds, burns, graft sites and cavity wounds; wound dressings; dressing materials for wounds, namely, medical pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help reduce wound odor; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help maintain an antiseptic wound healing environment

Owner & representation

OwnerRegenerex Pharma, Inc.
Address14 Main St, Building D,, Gordansville, TENNESSEE UNITED STATES 38563
EntityCORPORATION - organized in NEVADA
Attorney of recordChainey Singleton
CorrespondentChainey Singleton
Attorney emailc********@*****.com
Correspondent email2 emails
Correspondent phone1********7
Correspondent addressDallas, TEXAS
Full details in the report

Prosecution history 3 of 11 events

Nov 03, 2026
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 03, 2026
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 21, 2026
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
🔒 Full timeline (11 events) in the report

Ask about this record ✦ AI

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search